A comparison of combinatorial partitioning and linear regression for the detection of epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 Levels

Clinical Genetics

Volumn 62, Issue 1, 2002, Pages 74-79

  Moore, Jason H ^a   Lamb, J M ^a   Brown, N J ^a   Vaughan, D E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Combinatorial partitioning method; Epistasis; Gene gene interaction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CAUCASIAN; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; FIBRINOLYSIS; GENE DELETION; GENE INSERTION; GENE INTERACTION; GENETIC EPISTASIS; GENETIC POLYMORPHISM; HUMAN; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MALE; NEGRO; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; DATA INTERPRETATION, STATISTICAL; EPISTASIS, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LINEAR MODELS; MALE; PEPTIDYL-DIPEPTIDASE A; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC;

INSERTION SEQUENCES;

EID: 0036665198     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620110.x     Document Type: Article

References (15)

1. Templeton AR. Epistasis and complex traits. In: Wade M, Brodie B III, Wolf J, eds. Epistasis and evolutionary process. Oxford: Oxford University Press, 2000: 41-57.
2. Cheverud JM, Routman EJ. Epistasis and its contribution to genetic variance components. Genetics 1995: 139: 1455-1461.
3. Nelson MR, Kardia SLR, Ferrell RE, Sing CF. A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Res 2001: 11: 458-470.
4. Harker LA, Mann KG. Thrombosis and fibrinolysis. In: Cardiovascular thrombosis: thrombocardiology and thromboneurology, Verstraete M, Fuster V, Tupol EJ, eds., 2nd edn. Philadelphia: Lippincott-Raven Publishers, 1998: 3-22.
5. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991: 324: 1098-1104.
6. Brown NJ, Nadeau JH, Vaughan DE. Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin. Thromb Haemost 1997: 77: 522-525.
7. Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 1998: 32: 965-971.
8. Brown NJ, Gainer JV, Stein CM, Vaughan DE. Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension 1999: 33: 1431-1435.
9. Vaughan DE. Angiotensin, fibrinolysis, and vascular homeostasis. Am J Cardiol 2001: 87: 18C-24C.
10. Ridker PM, Vaughan DE, Stampfer MJ et al. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Circulation 1992: 85: 1822-1827.
11. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965: 52: 591-611.
12. Royston JP. An extension of Shapiro and Wilk's W test for normality to large samples. Appl Stat 1982: 31: 115-124.
13. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Series B 1964: 26: 211-243.
14. Banzhaf W, Nordin P, Keller RE, Francone FD. Genetic programming: an introduction. San Francisco: Morgan. Kaufmann Publishers, Inc., 2001.
15. Ritchie MD, Hahn LW, Roodi N et al. Multifactor dimensionality reduction reveals high-order interactions among estrogen metabolism genes in sporadic breast cancer. Am J Hum Genet 1998: 69: 138-147.